Mesoblast (MESO) Return on Sales (2014 - 2023)
Mesoblast (MESO) posted quarterly Return on Sales of 0.12% for Q2 2023, down 2.0% year-on-year from 0.12% in Q2 2022, and down 20.65% on a QoQ basis from 0.1% in Q1 2023.
Mesoblast (MESO) Return on Sales (2014 - 2023) Analysis & Trends
Mesoblast (MESO) has reported Return on Sales for 10 consecutive years, with 0.12% the latest figure, recorded in Q2 2023.
- Quarterly Return on Sales fell 2.0% year-over-year to 0.12% in Q2 2023, while the trailing twelve-month figure through Jun 2023 was 0.1% (down 1.0% YoY) and the FY2025 annual result came in at 0.06%, up 9.0% from the prior year.
- Return on Sales fell to 0.12% in Q2 2023 per MESO's latest filing, from 0.1% in the prior quarter.
- Over the last five years, Return on Sales for MESO reached as high as 0.01% in Q2 2020 and fell as low as 0.22% in Q1 2019.
- A 5-year average of 0.1% and a median of 0.1% in 2022 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2019 — Return on Sales advanced 15 bps — and 2020, when it dropped 16 bps.
- Year by year, Return on Sales stood at 0.11% in 2019, then retreated by 10 bps to 0.12% in 2020, then soared by 39 bps to 0.08% in 2021, then tumbled by 53 bps to 0.12% in 2022, then decreased by 1 bps to 0.12% in 2023.
- According to Business Quant data, Return on Sales over the past three periods registered 0.12%, 0.1%, and 0.12% for Q2 2023, Q1 2023, and Q4 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 0.00% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mesoblast | 2.08 Bn | 1.95 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -0.12% |
| Mar 31, 2023 | -0.10% |
| Dec 31, 2022 | -0.12% |
| Sep 30, 2022 | -0.08% |
| Jun 30, 2022 | -0.09% |
| Mar 31, 2022 | -0.11% |
| Dec 31, 2021 | -0.08% |
| Sep 30, 2021 | -0.09% |
| Jun 30, 2021 | -0.06% |
| Mar 31, 2021 | -0.15% |
| Dec 31, 2020 | -0.12% |
| Sep 30, 2020 | -0.18% |
| Jun 30, 2020 | -0.01% |
| Mar 31, 2020 | -0.06% |
| Dec 31, 2019 | -0.11% |
| Sep 30, 2019 | -0.02% |
| Jun 30, 2019 | -0.09% |
| Mar 31, 2019 | -0.22% |
| Dec 31, 2018 | -0.18% |
| Sep 30, 2018 | -0.17% |